Large Cap Biotechs Rocketing Up:BIIB, GILD
Despite a flattish Dow and S&P, many life science stocks are surging ahead. There are many movers in the Rayno Biopharmaceutical Portfolio : Biogen Idec BIIB $277) up 10%, Gilead (GILD $74.40) up 3.88% and Regeneron (REGN $283) up 2.38%.
Clinical trial and regulatory news is the trigger. Biogen Idec (BIIB) won extended patent protection in Europe. Gilead (GILD) received a positive opinion on their HCV drug Sovaldi (R) from the European CHMP.
This was after a day when Life Science DX and Tools stocks were up big.Some of our new DX trades are up today: Luminex (LMNX) and NanoString (NSTG)
We also recently added Vertex (VRTX) at $62.50 and it is up again today to $67.
Details to follow.